Infinimmune Inc. raised $75 million in a series A round, co-led by Regeneron Ventures and Playground Global, to advance its IL-22-targeted IFX-101 and IL-13-targeted IFX-201 into the clinic in 2027 ...
Accutar Biotechnology Inc. has reported proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin-protein ligase binding moiety covalently bound to kinesin-like protein KIF11 (KSP; ...
After capturing the North American market with Wegovy (semaglutide) and Zepbound (tirzepatide), Novo Nordisk A/S and Eli Lilly and Co. are advancing blockbuster glucagon-like peptide-1 (GLP-1) ...
Fresh off a Nasdaq listing and $10 million financing, Polaryx Therapeutics Inc. is moving PLX-200, an oral reformulation of gemfibrozil, into an open-label, phase II basket trial across four ...
Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.
Biohaven Ltd.’s quest for non-dilutive financing ended, at least for now, in an agreement with SK Biopharmaceuticals Co. Ltd., as the pair made known Aug. 26 ...
New hires and promotions in the biopharma and med-tech industries, including: Aivita, Alk-Abello, Aptitude Medical, Atsena, Baxter, Becton & Dickinson, Betterlife ...
Clinical updates for biopharma and med tech, including data readouts and publications: Agenus, Akeso, Alkermes, Amgen, Apollo, Basking, Bausch, Corvus, Daré ...
Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have divulged heterocyclic compounds acting as calcitonin receptor (CALCR; CT-R) and/or amylin receptor 3 (AMYR3) ...
Casma Therapeutics Inc. has been awarded approximately $7.6 million in funding across two competitive grant programs from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to support Casma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results